BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15598589)

  • 21. Structural modification of Fas C-terminal tripeptide and its effects on the inhibitory activity of Fas/FAP-1 binding.
    Sawa E; Takahashi M; Kamishohara M; Tazunoki T; Kimura K; Arai M; Miyazaki T; Kataoka S; Nishitoba T
    J Med Chem; 1999 Aug; 42(17):3289-99. PubMed ID: 10464015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells.
    Takada E; Hata K; Mizuguchi J
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):569-76. PubMed ID: 18026729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
    Scheper MA; Sauk JJ; Nikitakis NG
    Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells.
    Ho YT; Lu CC; Yang JS; Chiang JH; Li TC; Ip SW; Hsia TC; Liao CL; Lin JG; Wood WG; Chung JG
    Anticancer Res; 2009 Oct; 29(10):4063-70. PubMed ID: 19846952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
    Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo.
    Lai FJ; Cheng CL; Chen ST; Wu CH; Hsu LJ; Lee JY; Chao SC; Sheen MC; Shen CL; Chang NS; Sheu HM
    Clin Cancer Res; 2005 Aug; 11(16):5769-77. PubMed ID: 16115915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of lysosomal cathepsins in naphthazarin- and Fas-induced apoptosis in oral squamous cell carcinoma cells.
    Johansson AC; Norberg-Spaak L; Roberg K
    Acta Otolaryngol; 2006 Jan; 126(1):70-81. PubMed ID: 16308258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
    Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of protein kinase C alpha, caspase-3, and survivin on apoptosis of oral cancer cells induced by staurosporine.
    Zhang YX; Yu SB; Ou-Yang JP; Xia D; Wang M; Li JR
    Acta Pharmacol Sin; 2005 Nov; 26(11):1365-72. PubMed ID: 16225760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1).
    Hakozaki M; Hojo H; Kikuchi S; Abe M
    Oncol Rep; 2007 Jan; 17(1):169-73. PubMed ID: 17143495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of excision repair cross-complementation gene in drug-resistant process of carboplatin administration in tongue squamous cell cancer (Tca8113)].
    Li X; Li Y; Qiu LH; Tong X; Wang QM; Li T
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Jul; 46(7):437-41. PubMed ID: 22041635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
    Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
    Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of gastrin receptor antagonist and cyclooxygenase-2 inhibitor on proliferation and apoptosis of gastric cancer cell].
    Sun WH; Su H; Zhang LJ; Shao Y; Xu HC; Zhang T; Xue YP; Ding GX; Cheng YL
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):250-4. PubMed ID: 16677505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
    Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
    Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
    Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.